Treatment of critically ill patients with cefiderocol for infections caused by multidrug-resistant pathogens: review of the evidence
Abstract Appropriate antibiotic treatment for critically ill patients with serious Gram-negative infections in the intensive care unit is crucial to minimize morbidity and mortality. Several new antibiotics have shown in vitro activity against carbapenem-resistant Enterobacterales (CRE) and difficul...
Main Authors: | Pierluigi Viale, Christian E. Sandrock, Paula Ramirez, Gian Maria Rossolini, Thomas P. Lodise |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2023-06-01
|
Series: | Annals of Intensive Care |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13613-023-01146-5 |
Similar Items
-
Empiric treatment of patients with sepsis and septic shock and place in therapy of cefiderocol: a systematic review and expert opinion statement
by: Andrea Cortegiani, et al.
Published: (2022-07-01) -
Clinical Outcome of Cefiderocol for Infections with Carbapenem-Resistant Organisms
by: Monirul I. Sajib, et al.
Published: (2023-05-01) -
Cefiderocol for the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Systematic Review of Currently Available Evidence
by: Chuanhai Wang, et al.
Published: (2022-04-01) -
Erratum: Cefiderocol for the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Systematic Review of Currently Available Evidence
by: Frontiers Production Office
Published: (2022-08-01) -
The solution to drug resistance of Gram-negative bacteria – Cefiderocol
by: Magdalena Kołodziej, et al.
Published: (2023-05-01)